Erythroderma as a presenting sign of juvenile overlap syndrome
Juvenile dermatomyositis (JDM), which is rarely presented with erythroderma, and juvenile morphea are both autoimmune connective tissue diseases. We report a 14-year-old male child with resistant generalized erythroderma and mild proximal muscle weakness
Sarah Hamdy Soliman +5 more
doaj +1 more source
Juvenile dermatomyositis is a rare autoimmune myopathy of childhood, associated with systemic vasculopathy, primarily affecting the capillaries. Panniculitis is seen histologically in about 10% of patients with dermatomyositis; however, its clinical ...
Dylan C Ginter +5 more
doaj +1 more source
Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. [PDF]
OBJECTIVES: To study muscle biopsy tissue from patients with juvenile dermatomyositis (JDM) in order to test the reliability of a score tool designed to quantify the severity of histological abnormalities when applied to biceps humeri in addition to ...
Pilkington, Clarissa A +22 more
core +1 more source
A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies [PDF]
Objectives: The paediatric idiopathic inflammatory myopathies (IIMs) are a group of rare chronic inflammatory disorders of childhood, affecting muscle, skin and other organs.
Juvenile Dermatomyositis Research Group +15 more
core +1 more source
Background The importance of developmentally appropriate transitional care in young people with juvenile-onset rheumatic and musculoskeletal disease is well recognised.
Janet E. McDonagh +5 more
doaj +1 more source
Resolution of calcinosis using bisphosphonates in overlap syndrome – a case report
Introduction Calcinosis cutis is a common complication of pediatric rheumatologic diseases. However, there is currently no consensus on first-line treatment.
Mitchell Platter +2 more
doaj +1 more source
Immunobiologics in juvenile dermatomyositis: a systematic review of promising therapeutic advances. [PDF]
Introduction To identify the most effective treatment for juvenile dermatomyositis (JDM), considering efficacy, safety, impact on patients and improvement in their quality of life. Material and Methods A systematic review was carried out comparing known
de Oliveira Rocha AM +2 more
europepmc +2 more sources
Background: Juvenile dermatomyositis is potentially life threatening rare autoimmune illness that mainly affects muscle and skin. Cutaneous features are useful in establishing the diagnosis of this disease.
Yuji Takahashi +7 more
doaj +1 more source
Juvenile dermatomyositis shows characteristic skin lesions. However, this does not rule out co‐occurring other autoimmune diseases, which may be more prominent regarding skin manifestations.
Aleksander Markovic +3 more
doaj +1 more source
Juvenile Dermatomyositis: A 20-year Retrospective Analysis of Treatment and Clinical Outcomes
Juvenile dermatomyositis is a rare childhood multisystem autoimmune disease involving primarily the skin and muscles, and it may lead to long-term disability.
Chi Sun +6 more
doaj +1 more source

